SCHEMBL1850481

SCHEMBL1850481

CCOC(=O)C(=O)N(Cc1ccc(C(F)(F)F)cc1)Cc1ccc(Br)c2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
NPSR1 Q6W5P4 1/20 0.38
ALOX5 P09917 1/20 0.38
MAPT P10636 1/20 0.38
ALDH1A1 P00352 2/20 0.37
LMNA P02545 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
TBXA2R P21731 1/20 0.36
PTGDR Q13258 1/20 0.36
PTGDR2 Q9Y5Y4 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
LSS P48449 1/20 0.35
PPARG P37231 2/20 0.35
PPARD Q03181 1/20 0.35
PPARA Q07869 1/20 0.35
TSPO P30536 1/20 0.35
EPHX2 P34913 1/20 0.35
TRPM8 Q7Z2W7 1/20 0.35
MTOR P42345 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1859073 0.88 MEN1 (0.42) MEN1KMT2ANPSR1MAPTALDH1A1
SCHEMBL1853170 0.82 MAPT (0.48) MEN1KMT2ANPSR1MAPTALDH1A1
SCHEMBL1856733 0.82 THRA (0.41) MEN1KMT2AALOX5TBXA2RPTGDR
SCHEMBL1851833 0.79 CYP3A4 (0.34) MEN1KMT2ANPSR1ALOX5ALDH1A1
SCHEMBL1855617 0.79 CYP3A4 (0.34) MEN1KMT2ANPSR1ALOX5ALDH1A1
SCHEMBL1855559 0.78 NPSR1 (0.45) MEN1KMT2ANPSR1MAPTALDH1A1
SCHEMBL1856298 0.77 SRD5A2 (0.50) MEN1KMT2ANPSR1MAPTALDH1A1
SCHEMBL1857833 0.77 TSHR (0.39) KMT2AMAPTALDH1A1LMNALSS
SCHEMBL1858001 0.76 MAPT (0.36) MEN1KMT2ANPSR1MAPTPPARD
SCHEMBL1854639 0.76 SPHK1 (0.37) TBXA2RPTGDRPTGDR2PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1470102-B1 SUBSTITUTED METHYLENE AMIDE DERIVATIVES AS MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPS) MERCK SERONO SA (CH) 2011-05-25 EP disclosed
US-7592477-B2 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (PTPs) LABORATOIRES SERONO SA (CH) 2009-09-22 US disclosed
US-20050124656-A1 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) APPLIED RESEARCH SYSTEMS ARS (NL) 2005-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124656-A1 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) PTPRS, PTPA, PTPMT1 MEN1 2496/4885KMT2A 740/4885NPSR1 817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.